Results 141 to 150 of about 20,614 (289)

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

open access: yesРациональная фармакотерапия в кардиологии, 2017
Aim. To study the effect of sacubitril/valsartan compared with valsartan on natriuresis, diuresis, blood pressure (BP) and the level of biomarkers in hypertensive patients.Material and methods.
Zh. D. Kobalava   +3 more
doaj   +1 more source

The Efficacy and Safety of Sacubitril/Valsartan Compared to Valsartan in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fractions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

open access: yesJournal of Clinical Medicine
Background: Sacubitril/valsartan improves heart failure (HF) outcomes in patients with heart failure with reduced ejection fraction (HFrEF). However, randomized controlled trials (RCTs) in patients with heart failure and mildly reduced ejection fraction (
Sharath Kommu, Richard L. Berg
semanticscholar   +1 more source

Congestion, decongestion, renal function and diuretics in (ESC) heart failure

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 730-732, April 2025.
Jan Biegus   +2 more
wiley   +1 more source

Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation in Cardiac Amyloidosis

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Left atrial appendage occlusion‐related outcomes in patients with amyloid cardiomyopathy. ABSTRACT Background Cardiac amyloidosis (CA) is frequently complicated by atrial fibrillation (AF), yet outcomes after left atrial appendage occlusion (LAAO) in this population remain poorly defined.
Abdul Hakim Almakadma   +10 more
wiley   +1 more source

Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis [PDF]

open access: yes, 2017
Objective: The recent Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH) trial suggested that implantable cardioverter defibrillators (ICDs) do not reduce overall mortality in patients ...
Beggs, Simon A.S.   +4 more
core   +1 more source

Investigating operational stability and causes of cofactor release in fold type I amine transaminase

open access: yesProtein Science, Volume 35, Issue 2, February 2026.
Abstract Amine transaminases (ATAs) are pyridoxal phosphate (PLP) dependent biocatalysts frequently employed in chiral amine synthesis. Yields of ATA‐catalyzed reactions often suffer from low enzyme operational stability due to weak interactions between the ATA and the aminated cofactor pyridoxamine phosphate (PMP), which can leak from the active site ...
Xuebin Feng   +2 more
wiley   +1 more source

Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials [PDF]

open access: yes, 2017
Neprilysin is a neutral endopeptidase and its inhibition increases bioavailability of natriuretic peptides, bradykinin, and substance P, resulting in natriuretic, vasodilatatory, and anti-proliferative effects.
Bavishi, Chirag   +4 more
core  

ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure [PDF]

open access: yes, 2017
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or ...
Aimo, Alberto   +15 more
core   +1 more source

Heart failure with improved ejection fraction (HFimpEF) in patients treated with sacubitril/valsartan (SV) [PDF]

open access: bronze, 2022
Mingyu Kong   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy